The FDA has published its long-awaited update to guidance to make sure clinical trials more closely reflect the range of patients that might be treated with a new therapy in the real world.

The company has already licensed its first allogenic CAR-T, UCART19, to Pfizer and Servier, who are currently conducting phase 1 trials in the UK. Skip to main content Wednesday 28 May 2025 ...

These judges ruled against Trump. Then their families came under attack. An intimidation campaign against federal judges who have ruled against the Trump administration has strained the judges and ...